Shanghai Haohai Biological Technology Co., Ltd. (HKG: 6826)

Shanghai Haohai Biological Technology Revenue

Shanghai Haohai Biological Technology had revenue of 670.37M CNY in the quarter ending September 30, 2024, with 0.22% growth. This brings the company's revenue in the last twelve months to 2.75B, up 8.60% year-over-year. In the year 2023, Shanghai Haohai Biological Technology had annual revenue of 2.65B with 24.59% growth.

• Revenue (ttm): 2.75B CNY
• Revenue Growth: +8.60%
• P/S Ratio: 3.14
• Revenue / Employee: 1.27M CNY
• Employees: 2,158
• Market Cap: 14.71B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.65B	523.76M	24.59%
Dec 31, 2022	2.13B	380.16M	21.72%
Dec 31, 2021	1.75B	425.69M	32.14%
Dec 31, 2020	1.32B	-271.07M	-16.99%
Dec 31, 2019	1.60B	49.67M	3.21%